Insider · CIK 0001805556

Hansard Adam

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001805556

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-14	APLTApplied Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−48.9K sh	$5.39	−$263K	732,919
2023-12-21	APLTApplied Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+400K sh	—	—	781,790
2023-11-30	APLTApplied Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−965 sh	$1.97	−$1,901.05	381,790
2023-09-27	APLTApplied Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−9,720 sh	$2.70	−$26.2K	382,755
2023-01-11	APLTApplied Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−4,495 sh	$0.91	−$4,090.45	92,475
2023-01-11	APLTApplied Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+300K sh	—	—	392,475
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−32.3K sh	—	—	0
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	+105K sh	—	—	104,665
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	+50K sh	—	—	50,000
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−21.1K sh	—	—	0
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	+21.1K sh	—	—	21,100
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−21.1K sh	—	—	0
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	+21.1K sh	—	—	21,100
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	+32.3K sh	—	—	32,339
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−105K sh	—	—	0
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−50K sh	—	—	0
2022-04-13	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+50K sh	—	—	50,000
2022-01-07	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+21.1K sh	—	—	21,100
2022-01-07	APLTApplied Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+31.7K sh	—	—	96,970
2021-12-14	APLTApplied Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+31.7K sh	—	—	65,270
2021-12-14	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+21.1K sh	—	—	21,100
2021-12-14	APLTApplied Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+31.7K sh	—	—	65,270
2021-05-26	APLTApplied Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−2,894 sh	$18.35	−$53.1K	33,570
2020-12-10	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+81.7K sh	—	—	81,700
2020-03-09	APLTApplied Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+179K sh	—	—	179,425
2020-03-09	APLTApplied Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+36.5K sh	—	—	36,464

Recent filings

Accepted (ET)
Mar 184
Hansard Adam0001096906-24-000493
SEC(opens sec.gov)
Dec 224
Hansard Adam0001209191-23-059634
SEC(opens sec.gov)
Dec 14
Hansard Adam0001209191-23-057115
SEC(opens sec.gov)
Sep 294
Hansard Adam0001209191-23-050890
SEC(opens sec.gov)
Jan 134
Hansard Adam0001209191-23-003288
SEC(opens sec.gov)
Aug 44
Hansard Adam0001209191-22-044460
SEC(opens sec.gov)
Apr 154
Hansard Adam0001209191-22-024535
SEC(opens sec.gov)
Jan 114/A
Hansard Adam0001209191-22-002964
SEC(opens sec.gov)
Jan 114
Hansard Adam0001209191-22-002968
SEC(opens sec.gov)

Companies

Applied Therapeutics, Inc.Chief Commercial OfficerAPLT

Address

C/O APPLIED THERAPEUTICS, INC. 545 5TH AVENUE, SUITE 1400

NEW YORK, NY, 10017